Picture of Mesa Laboratories logo

MLAB Mesa Laboratories Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Annual income statement for Mesa Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue103118134184219
Cost of Revenue
Gross Profit60.964.987109134
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses93.4110122180216
Operating Profit9.787.4912.44.73.32
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes8.623.432.33.57-0.389
Provision for Income Taxes
Net Income After Taxes7.531.353.271.870.93
Net Income Before Extraordinary Items
Extraordinary Items
Net Income7.481.353.271.870.93
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income7.481.353.271.870.93
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS3.610.360.650.3510.173
Dividends per Share